Your browser doesn't support javascript.
loading
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia.
Morabito, Fortunato; Tripepi, Giovanni; Moia, Riccardo; Recchia, Anna Grazia; Boggione, Paola; Mauro, Francesca Romana; Bossio, Sabrina; D'Arrigo, Graziella; Martino, Enrica Antonia; Vigna, Ernesto; Storino, Francesca; Fronza, Gilberto; Di Raimondo, Francesco; Rossi, Davide; Condoluci, Adalgisa; Colombo, Monica; Fais, Franco; Fabris, Sonia; Foa, Robin; Cutrona, Giovanna; Gentile, Massimo; Montserrat, Emili; Gaidano, Gianluca; Ferrarini, Manlio; Neri, Antonino.
Affiliation
  • Morabito F; Department of Onco-Hematology Azienda Ospedaliera (AO) Cosenza, Biotechnology Research Unit, Cosenza, Italy.
  • Tripepi G; Department of Hematology and Bone Marrow Transplant Unit, Augusta Victoria Hospital, Jerusalem, Israel.
  • Moia R; Centro Nazionale Ricerca Istituto di Fisiologia Clinica (CNR-IFC), Research Unit of Reggio Calabria, Reggio Calabria, Italy.
  • Recchia AG; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Boggione P; Department of Onco-Hematology Azienda Ospedaliera (AO) Cosenza, Biotechnology Research Unit, Cosenza, Italy.
  • Mauro FR; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Bossio S; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • D'Arrigo G; Department of Onco-Hematology Azienda Ospedaliera (AO) Cosenza, Biotechnology Research Unit, Cosenza, Italy.
  • Martino EA; Centro Nazionale Ricerca Istituto di Fisiologia Clinica (CNR-IFC), Research Unit of Reggio Calabria, Reggio Calabria, Italy.
  • Vigna E; Department of Onco-Hematology AO Cosenza, Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Storino F; Department of Onco-Hematology AO Cosenza, Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Fronza G; Department of Onco-Hematology Azienda Ospedaliera (AO) Cosenza, Biotechnology Research Unit, Cosenza, Italy.
  • Di Raimondo F; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Rossi D; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
  • Condoluci A; Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Colombo M; Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Fais F; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Fabris S; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Foa R; Department of Experimental Medicine, University of Genoa, Genoa, Italy.
  • Cutrona G; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Gentile M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Montserrat E; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Gaidano G; Department of Onco-Hematology AO Cosenza, Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Ferrarini M; Department of Hematology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Neri A; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Front Oncol ; 11: 684621, 2021.
Article in En | MEDLINE | ID: mdl-34408978

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Italia